Low-Dose Paclitaxel-Coated Balloons for Femoropopliteal Disease: Days of Future Past?

作者信息

Biondi-Zoccai Giuseppe, Spadafora Luigi, Giordano Arturo

机构信息

Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy; Mediterranea Cardiocentro, Naples, Italy.

Department of Clinical, Internal Medicine, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.

出版信息

JACC Cardiovasc Interv. 2023 Nov 13;16(21):2666-2669. doi: 10.1016/j.jcin.2023.08.040. Epub 2023 Oct 4.

DOI:10.1016/j.jcin.2023.08.040

PMID:37804289

Abstract

摘要

相似文献

Low-Dose Paclitaxel-Coated Balloons for Femoropopliteal Disease: Days of Future Past?

JACC Cardiovasc Interv. 2023 Nov 13;16(21):2666-2669. doi: 10.1016/j.jcin.2023.08.040. Epub 2023 Oct 4.

12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.首例人体随机研究的 12 个月结果： Ranger 紫杉醇涂层球囊用于股腘治疗。

JACC Cardiovasc Interv. 2018 May 28;11(10):934-941. doi: 10.1016/j.jcin.2018.01.276. Epub 2018 May 2.

Primary Patency of Long-Segment Femoropopliteal Artery Lesions in Patients with Peripheral Arterial Occlusive Disease Treated with Paclitaxel-Eluting Technology.采用紫杉醇洗脱技术治疗的外周动脉闭塞性疾病患者长段股腘动脉病变的原发性通畅率

Ann Vasc Surg. 2020 Jul;66:595-600. doi: 10.1016/j.avsg.2019.11.044. Epub 2019 Dec 18.

Drug-coated balloon treatment of complex femoropopliteal disease yields favorable and durable outcomes at 5 years.药物涂层球囊治疗复杂股腘动脉疾病5年疗效良好且持久。

Catheter Cardiovasc Interv. 2022 Dec;100(7):1284-1285. doi: 10.1002/ccd.30500.

1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study.紫杉醇涂层球囊治疗长段股腘动脉病变 1 年结果：来自 SFA-Long 研究的证据。

JACC Cardiovasc Interv. 2016 May 9;9(9):950-6. doi: 10.1016/j.jcin.2016.02.014.

Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease.紫杉醇涂层球囊血管成形术治疗股腘外周动脉疾病的安全性。

JACC Cardiovasc Interv. 2019 Dec 23;12(24):2515-2524. doi: 10.1016/j.jcin.2019.08.025. Epub 2019 Sep 28.

Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.紫杉醇洗脱球囊与标准球囊血管成形术治疗股浅动脉和腘动脉支架内再狭窄：PACUBA 试验 1 年结果。

JACC Cardiovasc Interv. 2016 Jul 11;9(13):1386-92. doi: 10.1016/j.jcin.2016.04.012.

Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain.药物涂层球囊治疗间歇性跛行和缺血性静息痛患者的股腘病变

Circ Cardiovasc Interv. 2019 Jan;12(1):e007730. doi: 10.1161/CIRCINTERVENTIONS.118.007730.

Clinical Randomized Trial Evaluating Novel, Microcrystalline, and Biocompatible Polymer Paclitaxel-Coated Balloon for the Treatment of Femoropopliteal Occlusive Disease: The BIOPAC Trial.

JACC Cardiovasc Interv. 2018 Dec 10;11(23):2436-2438. doi: 10.1016/j.jcin.2018.07.029.

Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment.雷杰紫杉醇涂层球囊在股腘段的初始随机研究的六个月结果。

J Endovasc Ther. 2017 Aug;24(4):459-467. doi: 10.1177/1526602817710770. Epub 2017 May 31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验